Breaking News: Tirzepatide Shortage Status

The FDA has officially updated the status of tirzepatide injection in their drug shortage database. According to the latest information, the shortage that began on December 15, 2022, is now considered resolved as of October 2, 2024. This update affects both Mounjaro and Zepbound formulations across all dosage strengths. For historical context, see our complete GLP-1 shortage analysis.

Key Timeline

  • Shortage Duration: 12/15/2022 - 10/02/2024
  • Affects all dosage strengths
  • Both Mounjaro and Zepbound
  • Category: Endocrinology/Metabolism

Understanding Pharmacy Availability

Despite the resolved status, the FDA acknowledges that patients may still encounter challenges when filling their prescriptions. This is particularly true for medications like tirzepatide that require special handling and storage. Several factors contribute to these local availability issues, even when the medication is not officially in shortage.

Key Factors Affecting Local Access

The FDA highlights several specific challenges that can affect medication availability at individual pharmacies. These factors are particularly relevant for refrigerated products like tirzepatide and medications that come in multiple dose strengths. Understanding these challenges can help patients better navigate their prescription fulfillment process.

What This Means for Patients

For patients using tirzepatide (either Mounjaro or Zepbound), this update has several important implications. While the official shortage status has been resolved, the reality at your local pharmacy may be more complex. You might still need to:

  • Call ahead to check specific dose availability
  • Work with your pharmacy to coordinate refill timing
  • Consider multiple pharmacy options in your area
  • Plan ahead for refills to account for potential delays

Consider using our GLP-1 Plotter to help track your medication schedule and plan refills around potential availability delays.

Available Formulations

Both Mounjaro and Zepbound are available in six dosage strengths. Use our GLP-1 Calculator to help manage dosing across different strengths:

  • 2.5 mg/0.5 mL
  • 5.0 mg/0.5 mL
  • 7.5 mg/0.5 mL
  • 10.0 mg/0.5 mL
  • 12.5 mg/0.5 mL
  • 15.0 mg/0.5 mL

Note: This article reflects the current FDA drug shortage status as of December 15, 2023. Local availability may vary. Always work with your healthcare provider and pharmacy to ensure consistent access to your medication.